TheraDoc Announces New Surveillance Tool to Track MRSA and Other Potent Multidrug-Resistant Infectious Diseases | Reuters.
TheraDoc®, the leading provider of clinical decision support technology in healthcare, today announced that it has started beta testing of a new computerized patient surveillance tool that will help hospitals monitor and manage screening programs for multidrug-resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus, or MRSA, which every year kills more people in the United States than AIDS. The MDRO Compliance Manager, designed for use with TheraDoc`s Infection Control Assistant® and its Expert System Platform® core technology, was created to help hospitals boost compliance with screening protocols by quickly identifying patients who should be tested and those who need to be isolated in order to reduce the spread of MRSA and other drug-resistant organisms to other patients, staff, and visitors.
